Africa (WHO region) vs Oman: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Africa (WHO region)
89.0%
in 2014
Oman
100.0%
in 2014
Africa (WHO region) rank
2nd
Oman rank
1st
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Africa (WHO region)
- Oman
How they compare
Oman currently reports 100.0% against 89.0% in Africa (WHO region), a difference of 11.0%.
That makes Oman's figure about 1.1 times Africa (WHO region)'s.
Across all 10 years both countries report, Oman has been ahead every year.
Africa (WHO region) ranks 2nd and Oman ranks 1st of 11 groups.
Oman has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 77.6% | 100.0% | 22.4% | Oman |
| 2010s | 85.0% | 97.6% | 12.6% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Africa (WHO region) or Oman?
- Oman, at 100.0% against 89.0% in Africa (WHO region) as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Africa (WHO region) and Oman?
- 11.0%, with Oman ahead.
- How many years of comparable data are there for Africa (WHO region) and Oman?
- 10 years are reported by both, from 2005 to 2014.
- How do Africa (WHO region) and Oman rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Africa (WHO region) ranks 2nd and Oman ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.